Frontier Biotechnologies Inc. (SHA:688221)
China
· Delayed Price · Currency is CNY 21.10
-0.40 (-1.86%)
At close: Apr 29, 2026
Frontier Biotechnologies Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | 3.46 | -268.05 | -201.38 | -328.96 | -356.76 | -260.06 | Upgrade
|
| Depreciation & Amortization | 43.02 | 43.02 | 22.59 | 45.36 | 51.28 | 44.04 | Upgrade
|
| Other Amortization | 0.59 | 0.59 | 19.63 | 1.37 | 1.3 | 1.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.03 | 0.03 | -0.02 | 3.08 | 0 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.42 | 3.42 | 36.7 | 3.22 | 0.01 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.06 | 1.06 | -84.18 | -16.66 | -19.94 | -38.01 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -2.21 | 0.41 | 1.6 | 1.22 | Upgrade
|
| Other Operating Activities | 25.95 | 30.91 | 23.38 | 9.2 | 7.27 | -7.19 | Upgrade
|
| Change in Accounts Receivable | -27.87 | -27.87 | 38.6 | 2.43 | -58.03 | 5.73 | Upgrade
|
| Change in Inventory | -19.11 | -19.11 | 9.49 | -3.39 | -17.37 | -21.97 | Upgrade
|
| Change in Accounts Payable | 5.83 | 5.83 | -35.11 | 16.56 | 99.38 | 24.83 | Upgrade
|
| Change in Other Net Operating Assets | 3.6 | 3.6 | - | 0.22 | 2.24 | 7.16 | Upgrade
|
| Operating Cash Flow | 39.96 | -226.59 | -172.52 | -267.17 | -289.04 | -243.07 | Upgrade
|
| Capital Expenditures | -14.69 | -29.86 | -18.6 | -129.35 | -140.37 | -327.15 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.03 | 0.03 | 0.24 | 0 | 0.16 | Upgrade
|
| Divestitures | 27.47 | 27.47 | 48.66 | - | - | - | Upgrade
|
| Investment in Securities | - | - | -236.49 | 284 | -1 | 271 | Upgrade
|
| Other Investing Activities | -163.03 | 175.04 | 15.62 | 17.81 | 24.11 | 37.73 | Upgrade
|
| Investing Cash Flow | -150.24 | 172.68 | -190.78 | 172.7 | -117.27 | -18.26 | Upgrade
|
| Long-Term Debt Issued | - | 361.85 | 393.93 | 312.8 | 202.57 | 279.69 | Upgrade
|
| Long-Term Debt Repaid | - | -362.62 | -287.7 | -216.64 | -220.84 | -32 | Upgrade
|
| Net Debt Issued (Repaid) | 105.29 | -0.77 | 106.23 | 96.16 | -18.27 | 247.68 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 195.67 | - | Upgrade
|
| Common Dividends Paid | -7.75 | -8.19 | -14.91 | -14.46 | -15.13 | -5.54 | Upgrade
|
| Other Financing Activities | -17.57 | -15.46 | -5.7 | -11.41 | -2.8 | -22.82 | Upgrade
|
| Financing Cash Flow | 79.97 | -24.42 | 85.61 | 70.29 | 159.46 | 219.32 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.1 | -0.05 | 0 | -0.05 | 0.16 | 0.23 | Upgrade
|
| Net Cash Flow | -30.41 | -78.38 | -277.68 | -24.23 | -246.68 | -41.78 | Upgrade
|
| Free Cash Flow | 25.27 | -256.45 | -191.12 | -396.52 | -429.42 | -570.22 | Upgrade
|
| Free Cash Flow Margin | 6.44% | -207.85% | -147.61% | -347.07% | -506.74% | -1407.84% | Upgrade
|
| Free Cash Flow Per Share | 0.07 | -0.69 | -0.51 | -1.06 | -1.18 | -1.58 | Upgrade
|
| Cash Income Tax Paid | 3.32 | 3.22 | 4.21 | -6.39 | -54.05 | -12.26 | Upgrade
|
| Levered Free Cash Flow | -114.58 | -39.18 | -371.35 | -343.6 | -403.69 | -482.68 | Upgrade
|
| Unlevered Free Cash Flow | -114.58 | -39.18 | -364.88 | -338.31 | -400.72 | -481.72 | Upgrade
|
| Change in Working Capital | -37.56 | -37.56 | 12.98 | 15.81 | 26.21 | 15.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.